We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

125 hedge funds and large institutions have $548M invested in TG Therapeutics in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 14

87% more capital invested

Capital invested by funds: $293M → $548M (+$255M)

67% more call options, than puts

Call options by funds: $17.4M | Put options by funds: $10.4M

15% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 33

15% more funds holding

Funds holding: 109 → 125 (+16)

0.43% more ownership

Funds ownership: 50.63% → 51.07% (+0.43%)

Holders
125
Holders Change
+16
Holders Change %
+14.68%
% of All Funds
2.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
31
Increased
38
Reduced
33
Closed
14
Calls
$17.4M
Puts
$10.4M
Net Calls
+$7M
Net Calls Change
+$5.42M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$31.6M
2
ACA
Avoro Capital Advisors
New York
+$24.7M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.72M
4
HCMT
Highland Capital Management (Texas)
Texas
+$5.93M
5
Millennium Management
Millennium Management
New York
+$4.98M

Top Sellers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
-$25.8M
2
SAM
Senzar Asset Management
New York
-$11.2M
3
KCM
Kennedy Capital Management
Missouri
-$4.8M
4
State Street
State Street
Massachusetts
-$3.75M
5
JP Morgan Chase
JP Morgan Chase
New York
-$3.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJA
26
Raymond James & Associates
Florida
$3.21M +$184K +14,422 +7%
UBS Group
27
UBS Group
Switzerland
$2.9M +$1.65M +128,766 +171%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$2.78M +$1.37M +107,253 +122%
Citadel Advisors
29
Citadel Advisors
Florida
$2.7M +$1.09M +85,669 +82%
Deutsche Bank
30
Deutsche Bank
Germany
$2.64M +$867K +67,808 +57%
Group One Trading
31
Group One Trading
Illinois
$2.58M +$614K +48,084 +36%
HP
32
Hikari Power
Japan
$2.27M – – –
Morgan Stanley
33
Morgan Stanley
New York
$2.25M -$274K -21,461 -12%
Allianz Asset Management
34
Allianz Asset Management
Germany
$2.22M +$233K +18,231 +13%
EP
35
Eversept Partners
New York
$2.13M +$1.92M +150,000 New
RJFSA
36
Raymond James Financial Services Advisors
Florida
$1.98M +$8.78K +687 +0.5%
TCIM
37
TIAA CREF Investment Management
New York
$1.74M -$6.95K -544 -0.4%
QIM
38
Quantitative Investment Management
Virginia
$1.64M +$1.48M +115,600 New
TA
39
Teachers Advisors
New York
$1.59M +$297K +23,223 +26%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.51M – – –
Wellington Management Group
41
Wellington Management Group
Massachusetts
$1.51M +$1.35M +106,021 New
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$1.47M +$10.2K +800 +0.8%
GH
43
GAM Holding
Switzerland
$1.4M – – –
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.37M +$88.2K +6,900 +8%
PI
45
Putnam Investments
Massachusetts
$1.31M +$1.18M +92,543 New
Citigroup
46
Citigroup
New York
$1.31M -$470K -36,806 -28%
VEA
47
Virtus ETF Advisers
New York
$1.28M +$615K +48,087 +115%
TI
48
Trexquant Investment
Connecticut
$1.22M +$239K +18,700 +28%
CS
49
Credit Suisse
Switzerland
$1.13M +$157K +12,269 +18%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$1.11M -$35K -2,741 -3%
1
2
3 4 5

TGTX Hedge Fund Activity: Q1 2018 in Review

125 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q1 2018, worth a combined $548M — up 87% from $293M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TGTX positions and 14 closed out — a net gain of 17 holders — while 38 added to existing stakes and 33 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $31.6M. The largest seller was Bridger Management, cutting an estimated $25.8M.

  • 125 institutional investors held TG Therapeutics (TGTX) as of Q1 2018, up from 109 in Q4 2017.
  • Funds reported $548M of TG Therapeutics stock for Q1 2018, up 87% quarter-over-quarter.
  • 31 funds opened new TG Therapeutics positions in Q1 2018 and 14 closed out, a net change of +17 holders.
  • The largest TG Therapeutics buyer in Q1 2018 was RA Capital Management, an estimated $31.6M added.
  • The largest TG Therapeutics seller in Q1 2018 was Bridger Management, an estimated $25.8M sold.

Based on aggregated 13F filings for Q1 2018.